SERCEB established

A $45-million federal grant establishes the Southeast Regional Center of Excellence for Emerging Infections and Biodefense (SERCEB), a consortium of investigators from six regional universities who work to develop vaccines, drugs, and diagnostic tests against emerging infections such as SARS, and for defense against organisms that might be used in bioterrorist attacks. SERCEB is led by and centered at Duke.